longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Tigermed

300347

57.010.37% ( +0.21 )
Delay Closed: Sep 17, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 535.12, above the reasonable range, cheaper than 0% of the time in the past 5 years, and the industry ranks 19/27, the industry Median 51.74.

535.12xP/E
¥56.80Stock price
¥0.11Earnings per share
535.12xP/E
Stock price¥56.80Earnings per share¥0.11

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
43.44x
Typical range
26.49x–71.54x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 51.74x
0134268402536

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 51.74x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
300347SZTigermed
535.12x51.62%¥48.91B
688710SHInnoStar
528.41x--¥12.60B
301520SZAHWB
651.08x--¥6.36B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.